SIGNAL OF THE DAY

MMCAP International Inc. SPC cut Energy Fuels by 75.9% in Q3, then emerged as a major POET Technologies shareholder weeks later. This isn't rebalancing—it's rotation from uranium into AI photonics. When institutional money moves this fast between adjacent critical materials plays, it signals which supply chain bottleneck tightens first.

COVERAGE PULSE

POET: Eight awards since June 2024 and $150 million raised for AI optical market doubling to $10B by 2026, but dilution overshadows technical wins.

UUUU: $299 million ASM acquisition creates mine-to-metal rare earth chain as Goldman initiates Buy coverage ahead of February 27 earnings.

AG: 2025 profit of $211 million versus $101.9 million loss drove shares to all-time highs at $27.55. Dividends doubled to 2% of quarterly revenue as silver approaches $88.

PLSR: $10 million raised funds expanded drilling at Topaz where Jetstream #6 hit multiple pressurized gas zones exceeding 1,000 psi.

WHAT THE MARKET IS NOT TALKING ABOUT

Market breadth hit 65.8% of S&P 500 stocks above 200-day moving averages as Fundstrat's February rebalance shifts toward quality and defensive sectors. This rotation threatens valuation multiples supporting speculative small-caps, even as their fundamentals strengthen. The breadth expansion shows institutional money diversifying from concentrated AI bets just as infrastructure companies deliver commercial traction.

SIGNAL Cross-collateralization between AI infrastructure and critical materials creates systematic risk—when institutions rotate between POET and UUUU, it reveals which scarcity premium they believe will compress first.

ON THE RADAR - Next 7 Days

  • February 27: Energy Fuels 2025 earnings call at 9:00 AM MT—watch for ASM integration timeline and rare earth production ramp guidance
  • March 16: POET's Lightwave award presentation at OFC Conference—first major industry showcase since $150M raise
  • Through March: Pulsar's extended well testing phase concludes—flow test results will determine if helium play has commercial legs
--- DamonSkye Research Daily Brief. Not investment advice.
The author may hold positions in securities discussed in this publication. All positions, if any, will be consistent with the analytical thesis presented. DamonSkye Research discloses material holdings at the time of publication. This is not investment advice. See full disclaimer.